$BDX

Becton Dickinson ($BDX) sits at a crossroads — new AI-enabled product launches could drive medium-term margin recovery, while FY26 revenue pressure and recent underperformance keep upside limited near term. Analysts remain mostly positive but the company will need clearer execution and better top-line visibility to re-rate.